Delayed CRS-HIPEC Is Associated with Decreased Survival in Patients with Malignant Peritoneal Mesothelioma: A Markov Decision Analysis

J Gastrointest Surg. 2023 May;27(5):995-997. doi: 10.1007/s11605-022-05540-5. Epub 2022 Nov 28.
No abstract available

Keywords: Cytoreductive surgery; HIPEC; Malignant peritoneal mesothelioma; Markov; Time to treatment.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures
  • Decision Support Techniques
  • Humans
  • Hyperthermia, Induced*
  • Hyperthermic Intraperitoneal Chemotherapy
  • Mesothelioma* / pathology
  • Mesothelioma* / therapy
  • Mesothelioma, Malignant*
  • Peritoneal Neoplasms* / therapy
  • Retrospective Studies
  • Survival Rate